Ben Diner
FSA, MAAA
Consulting Actuary
New York, NY, US
Benjamin Diner is a consulting actuary with the New York office of Milliman. He joined the firm in 2022.
Experience
Benjamin specializes in pharmaceutical analyses, including market access research, payment model development, and health economics and outcomes research (HEOR) publications.
Prior to joining Milliman, Benjamin worked for a large national health plan where he developed ACA rate filings for several states.
Professional Designations
- Fellow, Society of Actuaries
- Member, American Academy of Actuaries
Education
- BS, Business Administration, New York University
Publications
Read their latest work
Article
4 considerations for life sciences companies related to Medicare Advantage and standalone PDP Star Ratings
25 November 2025 - by Rachel Crum, Ben Diner, Chris Page
We offer guidance to life sciences companies on Medicare Advantage and Star Ratings for standalone prescription drug plans.
Article
The evolution of biosimilars in the United States
08 November 2024 - by Jennifer Carioto, Melissa A. Caplen, Hanaa Siddiqi, Ben Diner
Biosimilars recently have made significant strides toward greater acceptance and utilization since their first U.S. approval in 2015, although challenges persist.